| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Nephrology |


* Department of Metabolic Medicine, Faculty of Medicine, Imperial College London, Hammersmith Hospital; and
Directorate of Renal and Transplant Medicine, Hammersmith Hospitals NHS Trust, Charing Cross Hospital, London, United Kingdom
Address correspondence to: Dr. Peter Choi, Renal Services, Ground Floor Pilot Wing, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK. Phone: +44-208-846-1754; Fax: +44-208-846-7589; E-mail: p.choi{at}imperial.ac.uk
Received for publication January 11, 2005. Accepted for publication March 29, 2005.
Anorexia and malnutrition confer significant morbidity and mortality to patients with end-stage kidney disease but are resistant to therapy. The aim of this study was to determine whether subcutaneous administration of ghrelin, an appetite-stimulating gut hormone, could enhance food intake in patients who are receiving maintenance peritoneal dialysis and have evidence of malnutrition. The principal outcome measure was energy intake during a measured study meal. Secondary outcome measures were BP and heart rate and 3-d food intake after intervention. Nine peritoneal dialysis patients with mild to moderate malnutrition (mean serum albumin 28.6 ± 5.0 g/L, total cholesterol 4.4 ± 0.6 mmol/L, subjective global assessment score of 5.7 ± 1.7) were given subcutaneous ghrelin (3.6 nmol/kg) and saline placebo in a randomized, double-blind, crossover protocol. Administration of subcutaneous ghrelin significantly increased the group mean absolute energy intake, compared with placebo, during the study meal (690 ± 190 versus 440 ± 250 kcal; P = 0.0062). When expressed as proportional energy increase for each individual, ghrelin administration resulted in immediate doubling of energy intake (204 ± 120 versus 100%; P = 0.0319). Administration of ghrelin maintained a nonsignificant increase in energy intake over 24 h after intervention (2009 ± 669 versus 1579 ± 330 kcal) and was not followed by subsequent underswing (1790 ± 370 versus 1670 ± 530 and 1880 ± 390 versus 1830 ± 530 kcal on days 2 and 3, respectively). Ghrelin administration resulted in a significant fall in mean arterial BP (P = 0.0030 by ANOVA). There were no significant adverse events during the study. Subcutaneous ghrelin administration enhances short-term food intake in dialysis patients with mild to moderate malnutrition.
This article has been cited by other articles:
![]() |
M. Yukawa, D. S. Weigle, C. D. Davis, B. T. Marck, and T. Wolden-Hanson Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1453 - R1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. B. Chaudhri, K. Wynne, and S. R. Bloom Can Gut Hormones Control Appetite and Prevent Obesity? Diabetes Care, February 1, 2008; 31(Supplement_2): S284 - S289. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Alvarez-Garcia, E. Garcia-Lopez, J. Rodriguez, H. Gil-Pena, I. Molinos, E. Carbajo-Perez, and F. Santos Administration of ghrelin to young uraemic rats increases food intake transiently, stimulates growth hormone secretion and does not improve longitudinal growth Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1309 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chang, C.-H. Hung, H.-L. Chen, K.-L. Hwang, and C.-Y. Lin Peritoneal transport characteristics and dwelling time significantly impact ghrelin clearance in peritoneal dialysis patients Nephrol. Dial. Transplant., January 1, 2007; 22(1): 224 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Murphy, W. S. Dhillo, and S. R. Bloom Gut Peptides in the Regulation of Food Intake and Energy Homeostasis Endocr. Rev., December 1, 2006; 27(7): 719 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S Dhillo, K. G Murphy, and S. Bloom Endocrinology: the next 60 years. J. Endocrinol., July 1, 2006; 190(1): 7 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kleinz, J. J. Maguire, J. N. Skepper, and A. P. Davenport Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man Cardiovasc Res, January 1, 2006; 69(1): 227 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W, Y. PX, L. BM, C. RD, M. DL, M. RH, I. H, O. MH, W. K, B.-J. K, et al. Anorexia and Cachexia in Renal Failure--Is Leptin the Culprit?: Role of Leptin and Melanocortin Signaling in Uremia-Associated Cachexia. J Clin Invest 115: 1659-1665, 2005 J. Am. Soc. Nephrol., August 1, 2005; 16(8): 2245 - 2250. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673